Part 2: Current Treatments and Rising Phase 3 Disease-Modifying Therapies |
|
Enduring |
|
$0.00 |
Across the Spectrum: Transforming the Detection and Management of Disease State Transitions Across the Spectrum of Multiple Sclerosis |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
|
Enduring |
|
$0.00 |
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management |
|
Enduring |
|
$0.00 |
The Path of Least Resistance: New Agents and Emerging Strategies for Managing Childhood-Onset and Refractory Epilepsies (Credit Expired) |
|
Enduring |
|
$0.00 |
Part 3: Evolving Roles in Alzheimer’s Disease Management: Team-Based Care in the Modern Age of Disease-Modifying Therapy |
|
Enduring |
|
$0.00 |
Part 3: Diagnostic and Therapeutic Monitoring Strategies and their Potential Role in the Future of Disease-Modifying Therapy for Alzheimer’s Disease |
|
Enduring |
|
$0.00 |
Inside Myasthenia Gravis: Where Providers and Patients Diverge on Defining Treatment Success |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
|
Enduring |
|
$0.00 |